Home : Unsafe Drugs : Adderall : Wikipedia : Shire plc

Wikipedia - Shire plc

  (Redirected from Shire Pharmaceuticals)
For other uses, see Shire (disambiguation).
Shire plc (formerly: Shire Pharmaceuticals Group Plc)
Type Public (LSE: SHP) (NASDAQ: SHPGY) (TSX:SHPGY-Q)
Industry Pharmaceuticals
Founded 1986
Headquarters Registered Office: St Helier, Jersey
Corporate HQ: Dublin, Ireland
UK Operations: Basingstoke, England
Key people Matthew Emmens, Chairman
Angus Russell, CEO
Revenue $3,007.7 million (2009)[1]
Operating income $620.2 million (2009)[1]
Net income $491.4 million (2009)[1]
Website www.shire.com

Shire plc (LSE: SHP), (NASDAQ: SHPGY), (TSX:SHPGY-Q) is a Jersey registered, Irish head quartered manufacturer of pharmaceuticals.[2] Originating in and with a large operational base in the United Kingdom, its brands and products include Adderall XR, Carbatrol, Fosrenol, and the recently released Vyvanse.

Contents

[edit] History

Shire was founded by Harry Stratford,Dr James Murray, Dennis Stepehens, Peter Moriarty, and Geoff Hall in 1986.[3] It was first listed on the London Stock Exchange in 1996[3] and in 1997 it went on to acquire Pharmavene and Richmond Pharmaceutical Company.[3] In 2007 it acquired New River Pharmaceuticals Inc, a leading US drug maker, for $2.3bn.[4]

[edit] Operations

The Company seeks to develop and market products within advanced biotechnology for specialty physicians. Shire’s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

The Company focuses its drug research and development on the relatively common mental abnormality Attention Deficit Hyperactivity Disorder (ADHD), as is made evident by the fact that three of its currently leading medications (Adderall/Adderall XR, Daytrana, and the newly developed Vyvanse), are intended for that disorder. However the Company also works on gastrointestinal (GI) treatments, human genetic therapies (HGT) and renal diseases.

[edit] Products

A container of Adderall XR
Name Annual revenue[5] Indication
Adderall XR $1.1B Attention Deficit Hyperactivity Disorder (ADHD)
Vyvanse $318.9M Attention Deficit Hyperactivity Disorder (ADHD)
Elaprase $305.1M Hunter syndrome (lysosomal storage disorder)
Pentasa $185.5M Gastrointestinal (Ulcerative colitis)
Replagal $176.1M Fabry disease (lysosomal storage disorder)
Fosrenol $155.4M Renal disease
Lialda/Mezavant $140.4M Gastrointestinal (Ulcerative colitis)
Daytrana $78.7M Attention Deficit Hyperactivity Disorder (ADHD)
Xagrid (sold as Agrylin in the U.S.) $78.7M Essential thrombocytosis
Carbatrol $75.9M Epilepsy
Calcichew (UK) $52.8M Calcium supplements
Reminyl/Reminyl XL $34.4M Alzheimer's disease
Firazyr $0.5M Cardiovascular (Hereditary angioedema)

[edit] Royalty income

Name Annual revenue[5] Indication Licensee
3TC (Lamivudine) $140.2M HIV GlaxoSmithKline
Zeffix (Lamivudine) $40.3M Chronic hepatitis B GlaxoSmithKline

[edit] Locations

The original corporate head quarters and still major operation base are located in Basingstoke, Hampshire, England. Other major offices are located in the United States in Wayne, Pennsylvania and Cambridge, Massachusetts. In addition, Shire owns a manufacturing site in Owings Mills, Maryland.

In 2008, in reaction to new taxation measures announced by the Labour Party in the treatment of royalties on patents, the company moved its tax domicile to Dublin, Ireland.[6] Effected through the creation of a new holding company in St Helier, Jersey in the Channel Islands, it will pay reduced tax on global earnings, where royalties on patents lodged in Ireland are tax free.

[edit] Corporate leadership

The non-executive Board Chairman is Matthew Emmens. Angus Russell is the Chief Executive Officer. The President of the Human Genetic Therapies division is Sylvie Gregoire and Michael Cola is the President of Specialty Pharmaceuticals.

[edit] References

  1. ^ a b c Preliminary Results 2009
  2. ^ "Contact Us". Shire plc. http://www.shire.com/shireplc/en/contactus. Retrieved 2010-01-03. 
  3. ^ a b c How Shire evolved
  4. ^ Shire buys New River
  5. ^ a b Shire Financial Summary 2008
  6. ^ Shire moves to Ireland to optimize tax

[edit] External links

Factory 1b.svg Companies portal
Retrieved from "http://en.wikipedia.org/wiki/Shire_plc"

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Shire plc".

Need An Adderall Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Looking for a District of Columbia Adderall attorney? Get in touch with one of our District of Columbia Adderall attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Adderall Case - Submit Your Information Below

Do you need legal assistance with your Adderall case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Adderall Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.
This form is secure and encrypted. More information about secure forms and your privacy here.